CN1970058A - Chinese medicinal formulation for treating diabetes - Google Patents
Chinese medicinal formulation for treating diabetes Download PDFInfo
- Publication number
- CN1970058A CN1970058A CN 200610161906 CN200610161906A CN1970058A CN 1970058 A CN1970058 A CN 1970058A CN 200610161906 CN200610161906 CN 200610161906 CN 200610161906 A CN200610161906 A CN 200610161906A CN 1970058 A CN1970058 A CN 1970058A
- Authority
- CN
- China
- Prior art keywords
- diabetes
- examples
- semen
- treatment
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicinal preparation for treating diabetes and complications, which is prepared from raw material herbs of tartary buckwheat, rhizoma dioscoreae, Chinese dates, coix seed, immature bitter orange and soybean through conventional procedures.
Description
Technical field
The present invention relates to treat the Chinese medicine preparation of diabetes and complication thereof.
Background technology
Whole world onset diabetes rate is the gesture that increases, and has become the chronic disease of the third-largest serious threat human health after tumor, cardiovascular diseases.Estimate that according to World Health Organization (WHO) by 2025, global maturity-onset diabetes patient's number will increase to 300,000,000, and Chinese diabetics number will reach 4,000 ten thousand.Diabetes will be serious public health problems of China in following 50 years.To treatment of diabetes, physician of all times has created the effective medicine of a large amount of treatment diabetes, but does not still have a kind of medicine that generally is suitable for, can cures diabetes at all so far.Most medicines are that too high blood glucose is lowered, and glucose in urine reduces or turns out cloudy, and relapse rate is very high after the drug withdrawal.Press the viewpoint of Chinese medicine, belong to " curing the symptoms, not the disease ".Some medicines also are easy to generate drug resistance, and a patient just must change types of drugs after certain medicine of use reaches certain hour, just can keep curative effect.Therefore, the medicine of seeking new effective treatment diabetes remains a task of medical circle.Particularly have no side effect, can fundamentally improve patient's whole body function status, clinical treatment is required especially to have the medicine of late result.
In view of the treatment of diabetes medicine must be eaten, Dun Dun eats everyday, therefore, the medicine for the treatment of and nutrition is combined as a whole is eaten shared product be fit to.
Summary of the invention
Technical problem to be solved by this invention is, a kind of Chinese medicine preparation is provided, and it is effective in cure to type ii diabetes, can improve patient's whole body functional condition especially, both can do medicine, also can make food.
The Chinese medicine preparation that the present invention treats diabetes is the medicament of being made by following raw materials by weight percent medicine:
Radix Et Rhizoma Fagopyri Tatarici 40%～52% Rhizoma Dioscoreae 15%～20% Fructus Jujubae 10%～15%
Semen Coicis 10%～15% Semen Euryales 4%～7% Semen Glycines 4%～8%.
Above-mentioned raw materials medicine percentage by weight preferable range is:
Radix Et Rhizoma Fagopyri Tatarici 45%～50% Rhizoma Dioscoreae 16%～18% Fructus Jujubae 12%～14%
Semen Coicis 12%～14% Semen Euryales 3%～6% Semen Glycines 3%～7%.
Above-mentioned raw materials medicine optimum weight percentage ratio is:
Radix Et Rhizoma Fagopyri Tatarici 50% Rhizoma Dioscoreae 20% Fructus Jujubae 10% Semen Coicis 10% Semen Euryales 5% Semen Glycines 5%.
Chinese medicine thinks, the main pathogenesis of diabetes is that the deficiency of YIN is scorching, the deficiency of vital energy and blood stasis, and clinical practice also confirms the deficiency of vital energy, the blood stasis overall process through the diabetes development.Blood stasis is one of basic pathology of diabetes, and it causes blood viscosity to increase, slow blood flow, and microcirculation disturbance, internal organs perfusions reduces, the tissue ischemia anoxia, thus have influence on the function of each internal organs, produce various complication.
Solution of the present invention is based on motherland's medical science to diabetes and pathogenetic understanding of complication and Therapeutic Principle, viewpoint according to " expectorant blood homology ", " the same stasis of blood of expectorant blood ", provide a kind of have blood sugar lowering, blood fat reducing by blood circulation promoting and blood stasis dispelling, improve high blood coagulation state, enhancing human body immunity power, the Remedies for diabetes of diabetes-alleviating and complication effect thereof.
Characteristics of the present invention are that general flavone content and mainly is a pentahydroxyflavone greater than 2.0% in the product.Studies show that, this flavone compound has effects such as heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, easing pain and diminishing inflammation, antioxidation, coronary artery dilator, elimination free radical, can blood fat reducing, blood viscosity lowering, promotion microcirculation, increase the islets of langerhans blood perfusion, help the synthetic and secretion of insulin, thereby improve the immunity of human body.
The present invention proves through 187 routine diabetics clinical verifications, and edible (30 a days) blood fat reducing course of treatment, blood sugar decreasing effect are obvious.
The specific embodiment
Embodiment 1 makes powder
Choose high-quality Radix Et Rhizoma Fagopyri Tatarici 500g, Rhizoma Dioscoreae 200g, Fructus Jujubae 100g, Semen Coicis 100g, Semen Euryales 50g, Semen Glycines 50g, carry out drying after the remove impurity, cross 100～120 mesh sieves behind the pulverize separately, mix homogeneously afterwards, high temperature sterilize is promptly.Take after mixing it with water with warm water when taking, or be washed into the clothes of eking out a living with warm water.Every day 1～4 time, each 10～30g.Determine according to the state of an illness course of treatment, generally at 30～180 days.
One of embodiment 2 clinical verifications
This group is 16 routine type ii diabetes patients, male patient's 7 examples wherein, female patient 9 examples; Age, the mean age was 59.5 years old between 46～64 years old; The course of disease 5 months～12 years, average 2.7 years; Cardio-cerebrovascular complication is in various degree arranged, wherein coronary heart disease 6 examples, hypertension 5 examples, apoplexy sequela 2 examples, retinal hemorrhage 1 example more.
All case is all carried out diet control and was once taken 1～two or more antidiabetic drugs before being in hospital, the not good or end-of-dose failure of clinical display effect, and have the property of carrying out to increase the weight of tendency.All the patient all looks into fasting glucose, blood fat, hemorheology, glucose in urine, electrocardiogram before accepting diabetes preparation for treating of the present invention, after finishing the course of treatment, and the check These parameters, curative effect is judged in contrast before and after treating.
The diabetes preparation of in therapeutic process, pressing the preparation of embodiment 1 method for oral the present invention, every day 2 times, each 15～20g, logotype 30 days.
Therapeutic outcome: fasting glucose concentration soprano is 19.3mmol/L before the treatment, and minimum is 9.8mmol/L; Treatment back fasting glucose concentration drops to the following person of 7mmol/L 7 examples, drops to 5 examples that have of 7～8.5mmol/L, and drops to 4 examples that have of 8.5～9.5mmol/L.
Cholesterol concentration is in above person's 11 examples of 5.9mmol/L before the treatment; Triglyceride concentration is in above person's 10 examples of 1.8mmol/L.Treatment back cholesterol concentration drops to following person's 8 examples of 5.9mmol/L, and triglyceride drops to following person's 6 examples of 1.8mmol/L.
The relevant index of hemorheology shows, severe is unusual before the treatment 7 examples, and paranormal have 5 examples; Only there are 3 examples that slight erythrocyte aggregation phenomenon is arranged after the treatment.
Treatment back 6 routine coronary heart disease, the 3 examples ventricular premature contraction that takes place frequently disappears, and electrocardiogram myocardial ischemia situation has in various degree to be improved.The hyperpietic cooperates an amount of depressor, among the 5 routine patients, has 3 examples to be controlled in normal range.2 routine apoplexy sequela patients are through treatment, and its language and limbs ability have slight improvement, have obviously before limbs pain and numb person treat to alleviate.
Two of embodiment 3 clinical verifications
This group is totally 13 routine patients, male's 7 examples wherein, women's 6 examples; Age, the mean age was 58 years old at 42～78 years old, and diabetic history is 2～28 years, type i diabetes 2 examples wherein, type ii diabetes 11 examples; Wherein merge coronary heart disease 4 examples, hyperlipemia 3 examples, diabetic nephropathy 3 examples, cerebral infarction 3 examples.
Therapeutic Method: the Western medicine antidiabetic drug of stopping using in principle, longer to the course of disease, the patient that the state of an illness is heavier, for the blood glucose rebound phenomenon that prevents to occur behind the inactive Western medicine, when using medicine of the present invention, the temporarily continuous usefulness of the Western medicine antidiabetic drug of its former usefulness, but consumption reduces to minimum maintenance dose, and using medicine of the present invention after 1 week, the blood sugar lowering Western medicine of stopping using.All cases all give the diabetes preparation by the preparation of embodiment 1 method, and instructions of taking is the every day of sub-service sooner or later 30g, and 30 days is a course of treatment, generally takes 1～3 course of treatment.Per 2～4 weeks adopt very sugared method to measure fasting glucose; Adopt the zymetology method to measure cholesterol, triglyceride and hemorheology; It is qualitative to adopt morning conventional method to measure glucose in urine on every Mondays.
Efficacy evaluation: after taking medicine of the present invention, produce effects 8 examples among the 13 routine patients, effective 4 examples, invalid 1 example, total effective rate reaches 92.3%.
Claims (4)
1. a Chinese medicine preparation for the treatment of diabetes is characterized in that, it is the medicament of being made by following raw material medicines in percentage by weight:
Radix Et Rhizoma Fagopyri Tatarici 40%～52% Rhizoma Dioscoreae 15%～20% Fructus Jujubae 10%～15%
Semen Coicis 10%～15% Semen Euryales 4%～7% Semen Glycines 4%～8%.
2. according to the said Chinese medicine preparation of claim 1, it is characterized in that the percentage by weight of described crude drug is:
Radix Et Rhizoma Fagopyri Tatarici 45%～50% Rhizoma Dioscoreae 16%～18% Fructus Jujubae 12%～14%
Semen Coicis 12%～14% Semen Euryales 3%～6% Semen Glycines 3%～7%.
3. according to the said Chinese medicine preparation of claim 1, it is characterized in that the percentage by weight of described crude drug is:
Radix Et Rhizoma Fagopyri Tatarici 50%, Rhizoma Dioscoreae 20%, Fructus Jujubae 10%, Semen Coicis 10%, Semen Euryales 5%, Semen Glycines 5%.
4. according to the Chinese medicine preparation of the described treatment diabetes of the arbitrary claim of claim 1～3, it is characterized in that its preparation form is a powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610161906 CN1970058A (en) | 2006-12-07 | 2006-12-07 | Chinese medicinal formulation for treating diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610161906 CN1970058A (en) | 2006-12-07 | 2006-12-07 | Chinese medicinal formulation for treating diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1970058A true CN1970058A (en) | 2007-05-30 |
Family
ID=38111206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610161906 Pending CN1970058A (en) | 2006-12-07 | 2006-12-07 | Chinese medicinal formulation for treating diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1970058A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106620090A (en) * | 2017-02-24 | 2017-05-10 | 贵州神奇老年病研究院 | Composition for reducing blood glucose, and preparation method of composition |
| CN107616451A (en) * | 2017-10-31 | 2018-01-23 | 十堰市绿田生物科技有限公司 | Yam and Job's tear seed semen Euryales nutritional powder |
| CN111759963A (en) * | 2020-06-15 | 2020-10-13 | 孙晓宣 | Meal replacement powder for treating diabetes and preparation method thereof |
-
2006
- 2006-12-07 CN CN 200610161906 patent/CN1970058A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106620090A (en) * | 2017-02-24 | 2017-05-10 | 贵州神奇老年病研究院 | Composition for reducing blood glucose, and preparation method of composition |
| CN107616451A (en) * | 2017-10-31 | 2018-01-23 | 十堰市绿田生物科技有限公司 | Yam and Job's tear seed semen Euryales nutritional powder |
| CN111759963A (en) * | 2020-06-15 | 2020-10-13 | 孙晓宣 | Meal replacement powder for treating diabetes and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102028900B (en) | Traditional Chinese medicine for treating metabolic syndrome and preparation method thereof | |
| CN100435831C (en) | Preparation for treating high blood pressure, high blood fat, obesity, and climacteric syndrome, and preparation method | |
| CN102526478B (en) | Formula of health-care medicine with functions of strengthening immunity and reducing blood sugar | |
| CN102205108B (en) | Traditional Chinese medicine preparation for treating gastric ulcer and preparation method thereof | |
| CN102100828A (en) | Medicament for treating diabetes mellitus | |
| CN108524673A (en) | A kind of Chinese medicine composition and its application | |
| CN101204559A (en) | Medicaments composite for coronary heart disease, angina and epigastralgia and preparation method thereof | |
| CN1857458A (en) | Health product and medicine and their preparing method | |
| CN103251796B (en) | Traditional Chinese medicine for treating insomnia | |
| CN1970058A (en) | Chinese medicinal formulation for treating diabetes | |
| CN100509025C (en) | A medicine for treating diabetes | |
| CN101530565B (en) | Chinese traditional medicine preparation used for curing diabetes and preparation method thereof | |
| CN101279034B (en) | Combined Chinese medicament for curing diabetic with combined internal and external therapies and preparation thereof | |
| CN102008627A (en) | Traditional Chinese medicinal preparation for treating diabetic retinopathy | |
| CN102579688B (en) | Blood pressure reducing chrysanthemum and dogbane leaf traditional Chinese medicine preparation | |
| CN104474103A (en) | Natural plant hypoglycemic agent and preparation method thereof | |
| CN100339119C (en) | Traditional Chinese medicine prepns. for treating diabete | |
| CN101053595B (en) | Medicinal preparation for treating constipation and its preparing method | |
| CN1695696A (en) | Wasting-thirst capsule of root powder for treating diabetes | |
| CN1318042C (en) | Application of barbat skullcap in preparing medication for treating diabetes | |
| CN105477102A (en) | Traditional Chinese medicine for treating type 2 diabetes | |
| CN102028811B (en) | Traditional Chinese medicine composite used for treating diabetes | |
| CN104027643A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN102697882A (en) | Angelica-containing Chinese medicinal oral liquid for treating chronic hepatitis and preparation method | |
| CN107898953A (en) | A kind of Chinese medicine composition for improving immunity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20070530 |